Answer
The treating healthcare professional should observe or monitor patients during and after a Vyepti (eptinezumab) infusion in accordance with normal clinical practice.
Sources for this answer
- Vyepti 100 mg concentrate for solution for infusion (300 mg not marketed)Lundbeck Limited · emc · SmPC §4.2 Posology and method of administration · Version 5Document updated
Sources checked